<div id="readability-page-1"><p>Channel Wealth LLC cut its stake in  Procter &amp; Gamble Company (The) (NYSE:PG - Free Report) by 68.2% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 4,647 shares of the company's stock after selling 9,977 shares during the period. Channel Wealth LLC's holdings in Procter &amp; Gamble were worth $714,000 as of its most recent SEC filing.</p><div><p><span></span><span>Get <strong>Procter &amp; Gamble</strong> alerts:</span></p></div><ul><li>3 Smart Defensive Stocks for an Uneasy Market</li></ul><p>Several other institutional investors and hedge funds have also recently bought and sold shares of PG. Kingstone Capital Partners Texas LLC grew its stake in shares of  Procter &amp; Gamble by 655,209.0% during the 2nd quarter. Kingstone Capital Partners Texas LLC now owns 76,028,952 shares of the company's stock valued at $11,832,680,000 after buying an additional 76,017,350 shares during the period.  Norges Bank acquired a new position in  Procter &amp; Gamble in the second quarter valued at $5,099,644,000.  Laurel Wealth Advisors LLC increased its stake in  Procter &amp; Gamble by 15,971.7% during the second quarter. Laurel Wealth Advisors LLC now owns 7,012,744 shares of the company's stock worth $1,117,270,000 after acquiring an additional 6,969,110 shares during the last quarter.  Vanguard Group Inc. raised its holdings in shares of  Procter &amp; Gamble by 1.4% in the 2nd quarter. Vanguard Group Inc. now owns 233,211,283 shares of the company's stock worth $37,155,222,000 after purchasing an additional 3,189,111 shares during the period.  Finally, Invesco Ltd. lifted its stake in shares of  Procter &amp; Gamble by 21.4% in the 2nd quarter. Invesco Ltd. now owns 16,374,499 shares of the company's stock valued at $2,608,785,000 after purchasing an additional 2,880,895 shares in the last quarter. Institutional investors and hedge funds own  65.77% of the company's stock. </p><h2>Wall Street Analyst Weigh In</h2><p>A number of analysts recently issued reports on the stock. Barclays dropped their target price on shares of Procter &amp; Gamble from $153.00 to $151.00 and set an &#34;equal weight&#34; rating for the company in a research report on Monday, December 8th. Jefferies Financial Group upgraded shares of Procter &amp; Gamble from a &#34;hold&#34; rating to a &#34;buy&#34; rating and boosted their price objective for the stock from $156.00 to $179.00 in a research note on Tuesday. JPMorgan Chase &amp; Co. raised their target price on shares of Procter &amp; Gamble from $163.00 to $165.00 and gave the company a &#34;neutral&#34; rating in a research note on Monday, October 27th. Weiss Ratings  restated a &#34;hold (c)&#34; rating on shares of Procter &amp; Gamble in a report on Monday. Finally, Morgan Stanley  set a $175.00 price target on Procter &amp; Gamble in a report on Monday, October 27th. Thirteen equities research analysts have rated the stock with a Buy rating and ten have given a Hold rating to the stock. According to data from MarketBeat, the stock  has an average rating of &#34;Moderate Buy&#34; and an average price target of $171.76.</p><ul><li>MarketBeat Week in Review – 10/27 - 10/31</li></ul><p><b>Get Our Latest Report on PG</b></p><h2>Procter &amp; Gamble Price Performance</h2><p>Shares of PG stock opened at $147.71 on Thursday. The firm has a fifty day simple moving average of $147.53 and a 200-day simple moving average of $153.78. The company has a market capitalization of $345.15 billion, a PE ratio of 21.56, a price-to-earnings-growth ratio of 4.88 and a beta of 0.39. Procter &amp; Gamble Company has a twelve month low of $138.14 and a twelve month high of $179.99. The company has a current ratio of 0.71, a quick ratio of 0.51 and a debt-to-equity ratio of 0.46. </p><ul><li>Wayfair: A Way Good Stock to Buy and Hold for 2026</li></ul><p>Procter &amp; Gamble (NYSE:PG - Get Free Report) last issued its quarterly earnings data on Friday, October 24th. The company reported $1.99 EPS for the quarter, topping analysts' consensus estimates of $1.90 by $0.09. The firm had revenue of $22.39 billion for the quarter, compared to analyst estimates of $22.23 billion. Procter &amp; Gamble had a net margin of 19.74% and a return on equity of 32.63%. The firm's revenue was up 3.0% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.93 EPS. Procter &amp; Gamble has set its FY 2026 guidance at 6.830-7.100 EPS.  Equities research analysts anticipate that  Procter &amp; Gamble Company will post 6.91 earnings per share for the current fiscal year. </p><h2>Procter &amp; Gamble Announces Dividend</h2><p>The firm also recently disclosed a quarterly dividend, which was paid on Monday, November 17th. Shareholders of record on Friday, October 24th were paid a dividend of $1.0568 per share. This represents a $4.23 dividend on an annualized basis and a yield of 2.9%. The ex-dividend date was Friday, October 24th. Procter &amp; Gamble's dividend payout ratio (DPR) is 61.75%. </p><h2>Insider Activity at Procter &amp; Gamble</h2><p>In other Procter &amp; Gamble news, insider Susan Street Whaley sold 2,408 shares of the company's stock in a transaction that occurred on Thursday, October 2nd. The stock was sold at an average price of $152.23, for a total value of $366,569.84. Following the transaction, the insider directly owned 31,770 shares of the company's stock, valued at $4,836,347.10. This represents a 7.05% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, COO Shailesh Jejurikar sold 3,986 shares of the stock in a transaction that occurred on Thursday, October 2nd. The shares were sold at an average price of $152.23, for a total value of $606,788.78. Following the transaction, the chief operating officer owned 46,899 shares of the company's stock, valued at approximately $7,139,434.77. This trade represents a 7.83% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold 30,308 shares of company stock worth $4,611,852 over the last ninety days. Company insiders own  0.20% of the company's stock. </p><h2>About Procter &amp; Gamble</h2> (Free Report)<p>Procter &amp; Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.</p><h2>Featured Articles</h2><ul><li>Five stocks we like better than Procter &amp; Gamble</li><li>Why Are These Companies Considered Blue Chips?</li><li>Post 35% Surge, Analysts Eye More Upside in Copper Giant Freeport</li><li>How to Know Which Cryptocurrency to Buy: A Guide for Investors</li><li>Why a SpaceX IPO Could Be a Major Catalyst for GOOGL Stock</li><li>Technology Stocks Explained: Here's What to Know About Tech</li><li>Can Upwork Maintain Its Comeback? Reasons to Be Bullish and Bearish</li></ul><p><strong>Want to see what other hedge funds are holding PG?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter &amp; Gamble Company (The) (NYSE:PG - Free Report).</p><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVBH?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVBH"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Procter &amp; Gamble Right Now?</h2><p>Before you consider Procter &amp; Gamble, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter &amp; Gamble wasn't on the list.</p><p>While Procter &amp; Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

<p>Channel Wealth LLC reduced its stake in Procter & Gamble by 68.2% in Q3, now holding 4,647 shares. Other institutional investors like Kingstone Capital and Norges Bank have increased their holdings. Analysts have mixed ratings, with a moderate buy consensus and an average price target of $171.76. Procter & Gamble's recent earnings exceeded expectations, with a quarterly EPS of $1.99 and revenue of $22.39 billion.</p>

Procter & Gamble Company (The) $PG Shares Sold by Channel Wealth LLC